Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
Renyu Zhang(Air Force Medical University), Huijie Bian(Air Force Medical University)
Cited by 92
Related Papers
Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress
|Hepatology|2018|99
Activation of TGF-β1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis
|Scientific Reports|2015|82
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial
|Signal Transduction and Targeted Therapy|2021|66
Challenges and processing strategies to produce high quality frozen meat
|Meat Science|2023|63
Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma
|Journal of Translational Medicine|2014|43